Texas Tech University Health Sciences Center (Lubbock)
Infectious Disease fellowship · Lubbock, TX · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Texas Tech University Health Sciences Center's research in infectious disease, which the program shares with other departments and affiliated hospitals.
About Texas Tech University Health Sciences Centerinstitution-wide infectious disease research
Infectious Disease publications from Texas Tech University Health Sciences Center and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
30
works per year
53rd of 71 infectious disease fellowship programs
-42.9%
2-year growth
55th of 71 infectious disease fellowship programs
4.9%
in top 10% of field (works before 2025)
65th of 67 infectious disease fellowship programs
13.6%
cited above world average
66th of 67 infectious disease fellowship programs
Works per year · * 2026 so far
Infectious Diseases · 147
Infectious Disease research topics at Texas Tech University Health Sciences Center
Papers in the window; each links to the list on OpenAlex.
- COVID-19 Clinical Research Studies 51
- Tuberculosis Research and Epidemiology 18
- Antifungal resistance and susceptibility 15
- SARS-CoV-2 and COVID-19 Research 12
- Clostridium difficile and Clostridium perfringens research 10
- Otolaryngology and Infectious Diseases 9
- Infection Control in Healthcare 7
- Viral Infections and Vectors 4
Most cited at Texas Tech University Health Sciences Center since 2024
All infectious disease papers there on OpenAlex
- Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trialSuzana Margareth Lobo et al. · EClinicalMedicine · 2024 · PubMed · cited 28
- SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamicsNadia Siles et al. · Communications Medicine · 2025 · PubMed · cited 12
- Live Attenuated Vaccines against Tuberculosis: Targeting the Disruption of Genes Encoding the Secretory Proteins of MycobacteriaRaja Veerapandian et al. · Vaccines · 2024 · PubMed · cited 11
- The ΔfbpAΔsapM candidate vaccine derived from Mycobacterium tuberculosis H37Rv is markedly immunogenic in macrophages and induces robust immunity to tuberculosis in miceAbhishek Mishra et al. · Frontiers in Immunology · 2024 · PubMed · cited 8
- Lupeol mitigates biofilm formation and attenuates virulence dimorphism in Candida albicansRavi Jothi et al. · Microbial Pathogenesis · 2025 · PubMed · cited 7
- Long non-coding RNA transcripts in Mycobacterium tuberculosis-host interactionsMahalakshmi Vijayaraghavan et al. · Non-coding RNA Research · 2024 · PubMed · cited 7
- Impact of Clostridioides difficile Infection on Clinical Outcomes in Hospitalized Patients With Inflammatory Bowel DiseaseShivangini Duggal et al. · Journal of Clinical Gastroenterology · 2025 · PubMed · cited 4
- Comparative transcriptomic analysis of mouse macrophages infected with live attenuated vaccine strains of Mycobacterium tuberculosisRaja Veerapandian et al. · Frontiers in Immunology · 2025 · PubMed · cited 4
- Clinical Characteristics and Patterns of Immune Responses in COVID-19 Patients From a Rural Community HospitalNinh My La-Beck et al. · Cureus · 2024 · PubMed · cited 4
- Hantavirus cardiopulmonary syndrome in children: a systematic scoping review of presentation, critical care management, and outcomesWeerapong Lilitwat et al. · Baylor University Medical Center Proceedings · 2026 · PubMed · cited 3